CN107440102A - A kind of climacteric women tailored version clinical nutrition formula and preparation method thereof - Google Patents
A kind of climacteric women tailored version clinical nutrition formula and preparation method thereof Download PDFInfo
- Publication number
- CN107440102A CN107440102A CN201710730062.1A CN201710730062A CN107440102A CN 107440102 A CN107440102 A CN 107440102A CN 201710730062 A CN201710730062 A CN 201710730062A CN 107440102 A CN107440102 A CN 107440102A
- Authority
- CN
- China
- Prior art keywords
- powder
- vitamin
- clinical nutrition
- climacteric women
- tailored version
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 46
- 230000035764 nutrition Effects 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 238000009472 formulation Methods 0.000 title abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 108
- 229940088594 vitamin Drugs 0.000 claims abstract description 38
- 229930003231 vitamin Natural products 0.000 claims abstract description 38
- 235000013343 vitamin Nutrition 0.000 claims abstract description 38
- 239000011782 vitamin Substances 0.000 claims abstract description 38
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 38
- 239000000203 mixture Substances 0.000 claims abstract description 33
- 235000015097 nutrients Nutrition 0.000 claims abstract description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 25
- 235000012054 meals Nutrition 0.000 claims abstract description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 23
- 230000035622 drinking Effects 0.000 claims abstract description 23
- 235000008216 herbs Nutrition 0.000 claims abstract description 23
- 230000010354 integration Effects 0.000 claims abstract description 23
- 235000013305 food Nutrition 0.000 claims abstract description 22
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 20
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 19
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 19
- 150000001875 compounds Chemical class 0.000 claims abstract description 17
- 239000011573 trace mineral Substances 0.000 claims abstract description 14
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 14
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 13
- 230000001804 emulsifying effect Effects 0.000 claims abstract description 6
- 238000001694 spray drying Methods 0.000 claims abstract description 6
- 238000003809 water extraction Methods 0.000 claims abstract description 5
- 239000003925 fat Substances 0.000 claims abstract description 4
- 235000013350 formula milk Nutrition 0.000 claims description 27
- 235000019197 fats Nutrition 0.000 claims description 25
- 239000002994 raw material Substances 0.000 claims description 20
- 235000018102 proteins Nutrition 0.000 claims description 18
- 235000015489 Emblica officinalis Nutrition 0.000 claims description 16
- 108010010803 Gelatin Proteins 0.000 claims description 16
- 239000000839 emulsion Substances 0.000 claims description 16
- 239000008273 gelatin Substances 0.000 claims description 16
- 229920000159 gelatin Polymers 0.000 claims description 16
- 235000019322 gelatine Nutrition 0.000 claims description 16
- 235000011852 gelatine desserts Nutrition 0.000 claims description 16
- 240000000950 Hippophae rhamnoides Species 0.000 claims description 14
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims description 14
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 14
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 14
- 235000010755 mineral Nutrition 0.000 claims description 14
- 239000011707 mineral Substances 0.000 claims description 14
- 241000196324 Embryophyta Species 0.000 claims description 13
- 239000000835 fiber Substances 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 244000046146 Pueraria lobata Species 0.000 claims description 12
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 12
- 235000014633 carbohydrates Nutrition 0.000 claims description 12
- 239000003814 drug Substances 0.000 claims description 12
- -1 phytosterol Chemical compound 0.000 claims description 12
- 244000119298 Emblica officinalis Species 0.000 claims description 11
- 235000007265 Myrrhis odorata Nutrition 0.000 claims description 11
- 235000012550 Pimpinella anisum Nutrition 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 9
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims description 7
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 7
- 229930003944 flavone Natural products 0.000 claims description 7
- 235000011949 flavones Nutrition 0.000 claims description 7
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 7
- 239000012141 concentrate Substances 0.000 claims description 6
- 239000003094 microcapsule Substances 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 6
- 239000003826 tablet Substances 0.000 claims description 6
- 125000001931 aliphatic group Chemical group 0.000 claims description 5
- 150000002213 flavones Chemical class 0.000 claims description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 4
- 239000000194 fatty acid Substances 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 240000002547 Rosa roxburghii Species 0.000 claims description 3
- 235000000640 Rosa roxburghii Nutrition 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims description 2
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 claims description 2
- 229920002307 Dextran Polymers 0.000 claims description 2
- 241000208688 Eucommia Species 0.000 claims description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 2
- 244000197580 Poria cocos Species 0.000 claims description 2
- 235000008599 Poria cocos Nutrition 0.000 claims description 2
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 claims description 2
- 241000219780 Pueraria Species 0.000 claims description 2
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 2
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 2
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims description 2
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 claims description 2
- 235000010081 allicin Nutrition 0.000 claims description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims description 2
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 claims description 2
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 2
- 235000020243 first infant milk formula Nutrition 0.000 claims description 2
- 229960002442 glucosamine Drugs 0.000 claims description 2
- 235000012680 lutein Nutrition 0.000 claims description 2
- 229960005375 lutein Drugs 0.000 claims description 2
- 239000001656 lutein Substances 0.000 claims description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 2
- 235000012661 lycopene Nutrition 0.000 claims description 2
- 229960004999 lycopene Drugs 0.000 claims description 2
- 239000001751 lycopene Substances 0.000 claims description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- 239000011812 mixed powder Substances 0.000 claims description 2
- 235000021283 resveratrol Nutrition 0.000 claims description 2
- 229940016667 resveratrol Drugs 0.000 claims description 2
- 238000012163 sequencing technique Methods 0.000 claims description 2
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 2
- 240000004760 Pimpinella anisum Species 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims 1
- 229920002498 Beta-glucan Polymers 0.000 claims 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 238000007873 sieving Methods 0.000 claims 1
- 230000001954 sterilising effect Effects 0.000 claims 1
- 230000003712 anti-aging effect Effects 0.000 abstract description 12
- 208000024891 symptom Diseases 0.000 abstract description 8
- 210000000056 organ Anatomy 0.000 abstract description 5
- 238000012545 processing Methods 0.000 abstract description 5
- 230000028327 secretion Effects 0.000 abstract description 5
- 239000005556 hormone Substances 0.000 abstract description 4
- 229940088597 hormone Drugs 0.000 abstract description 4
- 230000007102 metabolic function Effects 0.000 abstract description 3
- 206010065687 Bone loss Diseases 0.000 abstract description 2
- 238000012216 screening Methods 0.000 abstract description 2
- 230000002787 reinforcement Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 30
- 239000000463 material Substances 0.000 description 21
- 235000010469 Glycine max Nutrition 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 19
- 239000008280 blood Substances 0.000 description 19
- 230000006870 function Effects 0.000 description 17
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 13
- 244000068988 Glycine max Species 0.000 description 13
- 229910052791 calcium Inorganic materials 0.000 description 13
- 239000011575 calcium Substances 0.000 description 13
- 229960005069 calcium Drugs 0.000 description 13
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 12
- 239000003921 oil Substances 0.000 description 12
- 235000019198 oils Nutrition 0.000 description 12
- 229920002774 Maltodextrin Polymers 0.000 description 10
- 239000005913 Maltodextrin Substances 0.000 description 10
- 229940035034 maltodextrin Drugs 0.000 description 10
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 10
- 239000005862 Whey Substances 0.000 description 9
- 102000007544 Whey Proteins Human genes 0.000 description 9
- 108010046377 Whey Proteins Proteins 0.000 description 9
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 240000009023 Myrrhis odorata Species 0.000 description 8
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 8
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 239000003292 glue Substances 0.000 description 7
- 239000004006 olive oil Substances 0.000 description 7
- 235000008390 olive oil Nutrition 0.000 description 7
- 108090000765 processed proteins & peptides Proteins 0.000 description 7
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 7
- 206010027304 Menopausal symptoms Diseases 0.000 description 6
- 235000004347 Perilla Nutrition 0.000 description 6
- 244000124853 Perilla frutescens Species 0.000 description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 6
- 235000010489 acacia gum Nutrition 0.000 description 6
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 6
- 239000003240 coconut oil Substances 0.000 description 6
- 235000019864 coconut oil Nutrition 0.000 description 6
- 235000005911 diet Nutrition 0.000 description 6
- 230000037213 diet Effects 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 6
- 150000003271 galactooligosaccharides Chemical class 0.000 description 6
- 229910052742 iron Inorganic materials 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000001681 protective effect Effects 0.000 description 6
- 239000011435 rock Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 239000003549 soybean oil Substances 0.000 description 6
- 235000012424 soybean oil Nutrition 0.000 description 6
- 235000008939 whole milk Nutrition 0.000 description 6
- 239000011701 zinc Substances 0.000 description 6
- 229910052725 zinc Inorganic materials 0.000 description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- 240000003183 Manihot esculenta Species 0.000 description 5
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 5
- 240000009120 Phyllanthus emblica Species 0.000 description 5
- 108010073771 Soybean Proteins Proteins 0.000 description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 5
- 230000033228 biological regulation Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 210000003022 colostrum Anatomy 0.000 description 5
- 235000021277 colostrum Nutrition 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 239000004519 grease Substances 0.000 description 5
- 230000007062 hydrolysis Effects 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- 235000019710 soybean protein Nutrition 0.000 description 5
- 229960003080 taurine Drugs 0.000 description 5
- 235000019155 vitamin A Nutrition 0.000 description 5
- 239000011719 vitamin A Substances 0.000 description 5
- 239000011726 vitamin B6 Substances 0.000 description 5
- 229940045997 vitamin a Drugs 0.000 description 5
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 4
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- 229920001202 Inulin Polymers 0.000 description 4
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 235000008504 concentrate Nutrition 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 239000011162 core material Substances 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 229940011871 estrogen Drugs 0.000 description 4
- 239000000262 estrogen Substances 0.000 description 4
- 229960000304 folic acid Drugs 0.000 description 4
- 235000019152 folic acid Nutrition 0.000 description 4
- 239000011724 folic acid Substances 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 4
- 229940029339 inulin Drugs 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 229960003512 nicotinic acid Drugs 0.000 description 4
- 235000001968 nicotinic acid Nutrition 0.000 description 4
- 239000011664 nicotinic acid Substances 0.000 description 4
- 229940055726 pantothenic acid Drugs 0.000 description 4
- 235000019161 pantothenic acid Nutrition 0.000 description 4
- 239000011713 pantothenic acid Substances 0.000 description 4
- 229910052698 phosphorus Inorganic materials 0.000 description 4
- 239000011574 phosphorus Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- 239000011691 vitamin B1 Substances 0.000 description 4
- 239000011715 vitamin B12 Substances 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 239000011647 vitamin D3 Substances 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 229920001285 xanthan gum Polymers 0.000 description 4
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 3
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 3
- 241000512259 Ascophyllum nodosum Species 0.000 description 3
- 241000206575 Chondrus crispus Species 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 229960004203 carnitine Drugs 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000019688 fish Nutrition 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 229940091250 magnesium supplement Drugs 0.000 description 3
- 230000009245 menopause Effects 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N D-Maltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 2
- 229920002752 Konjac Polymers 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 206010051986 Pneumatosis Diseases 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical group [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 2
- 239000001354 calcium citrate Substances 0.000 description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
- MKJXYGKVIBWPFZ-CEOVSRFSSA-L calcium;(2s)-2-hydroxypropanoate Chemical compound [Ca+2].C[C@H](O)C([O-])=O.C[C@H](O)C([O-])=O MKJXYGKVIBWPFZ-CEOVSRFSSA-L 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000007969 cellular immunity Effects 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 230000002279 cholagogic effect Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000003132 food thickener Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 229940025878 hesperidin Drugs 0.000 description 2
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 238000001794 hormone therapy Methods 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000013337 tricalcium citrate Nutrition 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- QCHFTSOMWOSFHM-WPRPVWTQSA-N (+)-Pilocarpine Chemical compound C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C QCHFTSOMWOSFHM-WPRPVWTQSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- XQJMXPAEFMWDOZ-UHFFFAOYSA-N 3exo-benzoyloxy-tropane Natural products CN1C(C2)CCC1CC2OC(=O)C1=CC=CC=C1 XQJMXPAEFMWDOZ-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000143060 Americamysis bahia Species 0.000 description 1
- 244000247812 Amorphophallus rivieri Species 0.000 description 1
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000001759 Citrus maxima Nutrition 0.000 description 1
- 244000276331 Citrus maxima Species 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- PQMOXTJVIYEOQL-UHFFFAOYSA-N Cumarin Natural products CC(C)=CCC1=C(O)C(C(=O)C(C)CC)=C(O)C2=C1OC(=O)C=C2CCC PQMOXTJVIYEOQL-UHFFFAOYSA-N 0.000 description 1
- 241000371652 Curvularia clavata Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 240000005717 Dioscorea alata Species 0.000 description 1
- 241001324819 Dunaliella peircei Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 241000408747 Lepomis gibbosus Species 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- FSOGIJPGPZWNGO-UHFFFAOYSA-N Meomammein Natural products CCC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C2=C1OC(=O)C=C2CCC FSOGIJPGPZWNGO-UHFFFAOYSA-N 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 235000009812 Momordica cochinchinensis Nutrition 0.000 description 1
- 240000001740 Momordica dioica Species 0.000 description 1
- 235000018365 Momordica dioica Nutrition 0.000 description 1
- QQXLDOJGLXJCSE-UHFFFAOYSA-N N-methylnortropinone Natural products C1C(=O)CC2CCC1N2C QQXLDOJGLXJCSE-UHFFFAOYSA-N 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030247 Oestrogen deficiency Diseases 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 201000002451 Overnutrition Diseases 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 241001300674 Plukenetia volubilis Species 0.000 description 1
- 241000206607 Porphyra umbilicalis Species 0.000 description 1
- 206010036618 Premenstrual syndrome Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- QIZDQFOVGFDBKW-DHBOJHSNSA-N Pseudotropine Natural products OC1C[C@@H]2[N+](C)[C@H](C1)CC2 QIZDQFOVGFDBKW-DHBOJHSNSA-N 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- 241000287420 Pyrus x nivalis Species 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 229920000294 Resistant starch Polymers 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000196251 Ulva arasakii Species 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 235000019498 Walnut oil Nutrition 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 230000009858 acid secretion Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000001800 adrenalinergic effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 230000001004 anti-acetylcholinic effect Effects 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000703 anti-shock Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 1
- 229910001626 barium chloride Inorganic materials 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229940072440 bovine lactoferrin Drugs 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000002034 butanolic fraction Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- GRWVQDDAKZFPFI-UHFFFAOYSA-H chromium(III) sulfate Chemical compound [Cr+3].[Cr+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRWVQDDAKZFPFI-UHFFFAOYSA-H 0.000 description 1
- 231100000244 chromosomal damage Toxicity 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 210000003989 endothelium vascular Anatomy 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 210000000777 hematopoietic system Anatomy 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229940089536 indocin Drugs 0.000 description 1
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical group [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 239000000252 konjac Substances 0.000 description 1
- 235000010485 konjac Nutrition 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000001755 magnesium gluconate Substances 0.000 description 1
- 235000015778 magnesium gluconate Nutrition 0.000 description 1
- 229960003035 magnesium gluconate Drugs 0.000 description 1
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000011683 manganese gluconate Substances 0.000 description 1
- 235000014012 manganese gluconate Nutrition 0.000 description 1
- 229940072543 manganese gluconate Drugs 0.000 description 1
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 230000006386 memory function Effects 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000037345 metabolism of vitamins Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 230000003183 myoelectrical effect Effects 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 208000009928 nephrosis Diseases 0.000 description 1
- 231100001027 nephrosis Toxicity 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- GSSMIHQEWAQUPM-AOLPDKKJSA-N ovalbumin peptide Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CN=CN1 GSSMIHQEWAQUPM-AOLPDKKJSA-N 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 235000020823 overnutrition Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 150000002926 oxygen Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001335 perilla frutescens leaf extract Substances 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- SBNFWQZLDJGRLK-UHFFFAOYSA-N phenothrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 SBNFWQZLDJGRLK-UHFFFAOYSA-N 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Substances [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 235000020236 pumpkin seed Nutrition 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 235000021254 resistant starch Nutrition 0.000 description 1
- 210000001533 respiratory mucosa Anatomy 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229940091258 selenium supplement Drugs 0.000 description 1
- 230000014860 sensory perception of taste Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- CYHOMWAPJJPNMW-JIGDXULJSA-N tropine Chemical compound C1[C@@H](O)C[C@H]2CC[C@@H]1N2C CYHOMWAPJJPNMW-JIGDXULJSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000008170 walnut oil Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 210000004885 white matter Anatomy 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The present invention relates to a kind of climacteric women tailored version clinical nutrition formula, and it includes protein, fat, carbohydrate, dietary fiber, macroelement, trace element, liposoluble vitamin, water soluble vitamin, meals elite, integration of drinking and medicinal herbs composition, natural plants compound and new resource food;The invention further relates to the preparation method of above-mentioned clinical nutrition formula, powder is made in its each component in advance, and powder is made using alcohol extracting water extraction concentration, spray drying in integration of drinking and medicinal herbs composition, and vitamin and fat are handled by microencapsulation is made powder;Or powder is made to each component progress emulsifying homogeneous, spray drying by wet processing.Screening and proportioning by said components, nutrient formulation of the present invention provide the nutritional support of comprehensive abundance for climacteric women, to adjust female incretion, keep hormone normal secretions, alleviate climacteric various symptoms;Recover the metabolic function of reinforcement human body and organ, delay bone loss, anti-aging.
Description
Technical field
The present invention relates to special medicine purposes formula food field, and in particular to a kind of clinical battalion of climacteric women tailored version
Support formula and preparation method thereof.
Background technology
Climacteric refers to that the female middle-aged of 45-55 year stops the natural process of menstruation.Menopause also can be due to ovariectomized
Surgical operation or chemotherapy cause.Natural climacteric, which is one, includes premenopause (4~6 years), climacteric (not having menstruation in 1 year)
With the slow process of postmenopause.Involutional adverse reaction includes night sweat, flush, anxious state of mind, insomnia, fatigue etc., these
Reaction occurs at any time climacteric, but premenopause is most.Each women knows from experience difference for involutional, some
People's symptom is slight and some people are very heavy.
Control the intake of heat:Because climacteric is that women is stepped into an old transition period, machine by the middle age
Internal various functions start to weaken, and along with activity is reduced, basic metabolism reduces, the relative reduction of needs to heat, therefore
If do not paid attention to, reasonable diet is easy to get fat involutional women.As long as daily staple food can meet the requirement of body, no
It can eat and drink immoderately, in case overnutrition, causes middle aged " putting on weight ".
Ensure the supply of protein:Protein be maintenance and repair tissue material base, climacteric ovarian function
Degenerate, internal sex hormone reduces, and some tissue organ functions also fail therewith, to relax this degeneration, maintain its function, just needs
Ensure the intake of appropriate protein.
Low fat, low suger diet:Climacteric women decrease in estrogen, the adjustment effect of blood fat is weakened, often gone out
Existing high fat of blood.High fat diet can raise blood fat, and influence of the different aliphatic acid to blood fat is also different.Climacteric women is usually preferably taken the photograph
Enter appropriate polyunsaturated fatty acid, can significantly reduce cholesterol and low-density lipoprotein cholesterol level in blood plasma, and
TG will not be raised.
Multivitamin:Vitamin is a kind of organic substance necessary to maintaining human life activity, is also to maintain human body
The important active substances of physiological health.Although content of the vitamin in human body is seldom, it is in the growth of human body, development and new
Played an important role during old metabolism.The women to enter into the climacteric period, the intake of appropriate vitamin, body can be helped
Strengthen immunity, mitigate menopause symptom, also anti-aging, antitumaous effect.
Mineral matter needed by human:The vital movement of mineral matter and human body, metabolism, immunologic function, grow and
Body aging etc. is closely related.They are to maintain enzyme and the indispensable material of various hormonal activities.Climacteric women is due to body
Interior Ca,P metabolism is disorderly, sclerotin decalcification and osteoporosis easily occurs, it should be specifically noted that replenishing the calcium.
Dietary fiber and water:Cellulose can promote enterocinesia, keep free movement of the bowels, reduce noxious material and stop in enteron aisle
The time is stayed, there is protective effect on cancer risk;The absorption of carbohydrate can be delayed, advantageously reduce blood glucose;Portion of cellulose expands under one's belt,
People is allowed to produce satiety, so as to reduce the intake of heat.There is no water just there is no life, female middle-aged should be noted that to drink water more, this
Be advantageous to eliminate internal metabolite, beauty and the generation for preventing disease.
In a word, climacteric is women special and important period in life, will either step into involutional female
Property, be still in involutional women, will scientific rational diet nutritional, pass through diet care, mitigate climacteric
The malaise symptoms of phase, anti-aging.
Doctor trained in Western medicine thinks that the hypoestrogenemia of menopausal women is substantially the basis of menopausal symptom.Estrogen level
Excessively reduce, cause neurotransmitter, hormone, cell factor caused by the dysfunctions such as hypothalamic-pituitary-ovarian axis or adrenal gland
It is unbalance Deng producing, it is the main reason for menopausal syndrome occurs.
Traditional Chinese medicine thinks, this sick etiology and pathogenesis duty in kidney.Kidney qi degradation before and after climacteric, menses will exhaust, and punching, which is appointed, loses
Damage, asthenia of essence and blood, cause imbalance between YIN and YANG, function is disorderly and menopausal syndrome occurs.Clinical common parting is kidney
The deficiency of Yin, kidney-yang deficiency, kidney insufficiency, fire excess from yin deficiency, breakdown of the normal physiological coordination between the heart and the kidney, the insufficiency of both the spleen and the kindey, the insufficiency of heart and spleen, stagnation of liver qi, deficiency of Yin liver-yang hyperactivity,
Kidney deficiency folder stasis of blood etc..
Hormonotherapy is born in the forties in last century, is mainly used in improving menopausal syndrome, is only just had more than in the U.S.
40% climacteric women takes female hormone alternative medicine, but the climacteric women for only having 1% in China receives estrogen treatment
Method, many public are also unfamiliar with to this treatment means, and the security of particularly some menopausal syndromes patient for treatment has
Misgivings.Chinese medicine menopausal syndrome is curative for effect, few side effects, it is shown that good prospect.But traditional Chinese medicine is to climacteric
The shortages such as the etiology and pathogenesis of phase syndrome, differentiation of symptoms and signs for classification of syndrome, efficacy evaluation unified standard, clinical prescription is numerous and diverse, and research work is excessively
It is scattered.
Therefore, while development can provide the basal nutrient element needed for climacteric women, and can alleviates climacteric women
The product of symptom has important value and wide market.
The content of the invention
A kind of the defects of it is an object of the invention to overcome in the prior art, there is provided climacteric women tailored version clinical nutrition
Formula and preparation method thereof, it provides the nutritional support of comprehensive abundance for climacteric women, and researches and develops and be rich in vitamin B6And ammonia
Sour, the enough calcium of base and vitamin D, the product for having additional nutrients, improving passive protective physical fitness for supplementing appropriate estrogen, realize female
Property climacteric more preferable transition.Nutrient refers to provide energy to human body in food, participates in body composition and regulation of physiological functions
Chemical composition.Nutrition necessary to human body is known as protein, lipid, carbohydrate, mineral matter, vitamin, water, dietary fiber etc..
To achieve the above object, the present invention adopts the following technical scheme that:
First purpose of the present invention is to provide a kind of climacteric women tailored version clinical nutrition formula, including following component
And its parts by weight:15~20 parts of protein, 12~18 parts of fat, 40~54 parts of carbohydrate, 3.9~5.3 portions of property meals
Fiber, 0.7~1.6 part of macroelement, 0.01~0.04 part of trace element, 0.005~0.02 part of liposoluble vitamin, 0.1~
0.2 part of water soluble vitamin, 0.05~2 part of meals elite, 0.2~2 part of integration of drinking and medicinal herbs composition, 0.1~3 part of natural plants
Compound and 0.02~2 part of new resource food.
In order to further optimize above-mentioned clinical nutrition formula, the technical measures that the present invention is taken also include:
Preferably, the protein be selected from PURE WHEY, soybean protein isolate, hydrolysis Isin glue collagen, whole milk powder,
At least one of skimmed milk power, dried whole-egg, lactoferrin, bovine colostrum, amino acid, protein peptides;Wherein egg in whole milk powder
White matter content is 24wt%, fat content 34wt%, carbohydrate content 40wt%.
Wherein, the amino acid is selected from 1B-Pidolidone, Pidolidone, L-arginine, L-Trp, L- paddy
At least one of glutamine, taurine, Valine, ILE, L-Leu;The protein peptides are selected from soy oligosaccharides
In peptide, wheat protein peptide, pupa albumen peptide, ocean fish oligopeptide, laughable peptide, amino peptide, ovalbumin peptide, CCP
It is at least one.
It is highly preferred that the protein includes PURE WHEY, soybean protein isolate, whole milk powder, bovine colostrum, hydrolysis
Isin glue collagen, taurine.
Preferably, the fat includes saturated fatty acid, polyunsaturated fatty acid, monounsaturated fatty acids, OPO structures
At least one of fat, DHA, EPA, ARA, phosphatide, more specifically described fat include safflower seed oil, walnut oil, peanut oil,
Soybean oil, Ah's glycerine, olive oil, tea oil, oil and fat of sacha inchi, olive oil, coconut oil, perilla herb oil, deep sea fish oil, cupu oil, palm
Oil, butter, cream, lard, medium chain triglyceride, lecithin, Purple Perilla Seed Oil etc.;More preferably olive oil, soybean oil, coconut
Oil, perilla herb oil, medium chain triglyceride.
Preferably, in above-mentioned nutrient formulation, the weight ratio of ω -6 aliphatic acid and omega-fatty acid is 4:1.
Preferably, the carbohydrate is included in fructose, rock sugar, lactose, maltodextrin, tapioca, resistant starch
At least two;More preferably maltodextrin, tapioca, rock sugar.
Preferably, the dietary fiber include inulin, konjaku flour, galactooligosaccharide, FOS, oligoisomaltose,
At least one of soybean polyoses, cyclodextrin, resistant dextrin, soybean fiber;It is highly preferred that the dietary fiber includes 3~4 parts
Water-soluble dietary fiber and 0.9~1.3 part of insoluble diedairy fiber, it includes galactooligosaccharide and soybean fiber.
Preferably, the macroelement is selected from calcium citrate, L-calcium lactate, calcium monohydrogen phosphate, K-IAO, sodium citrate
At least one of with magnesium gluconate.
Preferably, the trace element is selected from ferrous gluconate, KI, zinc gluconate, sodium selenite, glucose
At least one of sour copper, chromium sulfate, manganese gluconate and sodium molybdate.
Preferably, the liposoluble vitamin is selected from vitamin A, beta carotene, vitamin D3, vitamin E, vitamin
K1At least one of.
Preferably, the water soluble vitamin is selected from vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin
C, at least one of pantothenic acid, folic acid, nicotinic acid, choline, inositol, biotin.
Preferably, the meals elite is selected from cereal, beans, potato class, greengrocery, Homonemeae, nut-seed class, fishes and shrimps
At least one of class, poultry meat, fruits;The cereal is selected from rice meal, millet powder, black rice flour, coixlacrymajobi powder, corn
At least one of powder, wheat germ powder, oatmeal, buckwheat;The beans is selected from peameal, mung bean flour, black bean powder, red bean
At least one of powder, soy meal;The potato class is mainly made up of common yam rhizome powder;The Vegetable powder is selected from carrot meal, white radish powder, south
At least one of melon powder, spinach powder, tomato meal, broccoli powder, balsam pear powder;The Homonemeae be selected from mushroom powder, Kelp Powder and
At least one of white fungus powder;The nut-seed class is selected from least one of pumpkin seed powder and lotus nut starch;The fish and shrimp
Selected from least one of salmon powder and cod meal;The poultry meat is selected from chicken meal, powdered beef, pork liver powder and pig kidney powder
At least one of;The fruits in red date powder, longan powder, apple powder, cherry powder, citrus powder, pyrus nivalis powder at least
It is a kind of;More preferably soy meal.
Preferably, the natural plants compound is selected from l-cn, Glucosamine, FOS, lutein, plant
At least one of sterol, lycopene, resveratrol, allicin;More preferably l-cn.
Preferably, the integration of drinking and medicinal herbs composition is selected from Poria cocos, orange, donkey-hide gelatin, orange peel, the root of kudzu vine, sea-buckthorn, emblic, anise
At least one of fennel.
It is highly preferred that the parts by weight of each component are as follows in the integration of drinking and medicinal herbs composition:Orange 0~1 part, donkey-hide gelatin 0~1
Part, 0~1 part of orange peel, 0~1 part of the root of kudzu vine, 0~1 part of sea-buckthorn, 0~1 part of emblic, 0~1 part of Chinese anise.
Preferably, the new resource food is selected from first milk basic protein, γ-aminobutyric acid, chitosan oligosaccharide, eucommia Bark male flower, bamboo
Leaf flavones, CPP, avenabeta glucosan, Oligomeric manna sugar, stachyose, Rosa roxburghii, yeast beta-dextran, newborn mineral
At least one of salt, pueraria root powder, xylo-oligosaccharide, L-arabinose;It is highly preferred that the new resource food be newborn mineral salt,
L-arabinose and γ-aminobutyric acid.
Above-mentioned nutrient formulation can also add appropriate seawood meal, more fully to supplement related nutritional element, improve climacteric
The health of women.The seawood meal includes seawater spirulina powder, chlorella powder, Dunaliella peircei powder, ulva lactuca powder, Kelp Powder, skirt
Vegetable powder, laver powder, kelp powder, Algemin, deer horn vegetable powder and kylin vegetable powder etc., food-borne marine algae is rich in algin, sweet dew
Alcohol, vitamin and multi mineral the prime element such as trace element such as potassium, iron, calcium, phosphorus, iodine, selenium, cobalt, also 10%- containing crude protein
40%, crude fat 0.30%-50%, carbohydrate 30%-60%.Scientific investigations showed that seawood meal can adjust human body
Metabolic function, strengthen immunity, health care, brain and enhancing intelligence, anti-aging are mended, Thyroid Gland Swell, nephrosis can be prevented, strengthen skin
Gloss and elasticity, softening blood vessel, reduce cholesterol;Obesity, hypertension, cardiovascular disease etc. can be prevented with lipid-loweringing, decompression.
Second object of the present invention is to provide a kind of preparation side of above-mentioned climacteric women tailored version clinical nutrition formula
Method method, it comprises the following steps:
Step 1) prepares fat powder, liposoluble vitamin powder and water soluble vitamin powder using micro-capsule embedding techniques
End;
Step 2) prepares integration of drinking and medicinal herbs component powders using crushing, alcohol extracting, water extraction, spray drying and sifting step;
Step 3) is smart by the protein of predetermined weight, carbohydrate, dietary fiber, macroelement, trace element, meals
China, natural plants compound and new resource food are prepared into the powder that particle diameter is 150~250 μm respectively, if desired
Above-mentioned raw materials can be carried out in advance baking processing;
Step 4) is by step 1)~3) sterilize after the powder for preparing is well mixed it is standby;
The mixed powder of step 4) is prepared into nutrient powder, nutrition emulsion, capsule by step 5) according to conventional technical means
At least one of agent, tablet, pill or oral liquid;
Wherein, step 1) -3) order can mutually change.
Finally, the present invention relates to a kind of product prepared by above-mentioned climacteric women tailored version clinical nutrition formula, including
Nutrient powder, nutrition emulsion, capsule, tablet, pill, oral liquid etc..
In above-mentioned preparation method, wherein, the raw material of the integration of drinking and medicinal herbs composition is crushed, alcohol extracting concentration, water extraction are dense
Contracting, and concentrate is subjected to spray drying integration of drinking and medicinal herbs component powders are made;Wherein, the vitamin and fat are respectively by micro-
Encapsulated processing is prepared into vitamin powder and fat powder.
Preferably, the preparation process of the integration of drinking and medicinal herbs component powders is as follows:Using pulverizer to predetermined weight number
Raw material is crushed, and the raw material of crushing is placed in container, adds 3~5 times of 60~80% second that weight is raw material weight
Alcohol, soaked, extracted 2 times, merged alcohol extract and be concentrated into no alcohol taste;After the active compound dregs of a decoction fling to ethanol, weight is added as original
6~8 times of water of material weight is soaked, and is carried out 30~60min of decoction to soak, is filtered off except raw material, leaves and takes decoction
Liquid;Merge alcohol extract and decoction liquor after concentration, and it is spray-dried, it is same finally to prepare medicine food with 60~80 mesh sieves point
Derived components powder.
Preferably, what the microencapsulation of the vitamin was handled comprises the following steps that:1) using liposoluble vitamin as core
Material, from sodium carboxymethylcellulose, gelatin, carragheen, xanthans, Arabic gum, maltodextrin, lipoprotein, corn syrup, big
Beans protein isolate, whole-fat milk powder, dietary fiber, inulin, PURE WHEY, oligoisomaltose, soybean fiber, lactose, rock sugar
One or more in powder, emulsifying agent, stabilizer high-pressure homogeneous emulsification, are sprayed instantaneous dry, with 60~80 mesh sieves as wall material
Divide and prepare liposoluble vitamin powder;2) using water soluble vitamin as core, from sodium carboxymethylcellulose, gelatin, OK a karaoke club
Glue, xanthans, Arabic gum, maltodextrin, lipoprotein, corn syrup, soybean protein isolate, whole-fat milk powder, dietary fiber, chrysanthemum
One or more works in powder, PURE WHEY, oligoisomaltose, soybean fiber, lactose, candy sugar powder, emulsifying agent, stabilizer
For wall material, it is well mixed, sprays instantaneous dry, water soluble vitamin powder is prepared with 60~80 mesh sieves point.
Preferably, the specific implementation step of the fatty micro-capsule embedding techniques is as follows:By fat, emulsifying agent, wall material with
Water mixed dissolution prepares emulsion;After above-mentioned emulsion is stirred, emulsifying homogeneous processing is carried out, it is dry then to carry out spraying
Dry, screening prepares fat powder, and fat powder is compared with conventional grease, and its dispersiveness, water solubility, emulsibility, inoxidizability are all
Improve a lot;Wherein, the emulsifying agent be selected from fatty acid glyceride (glyceride), methyl glycol fatty acid ester (propylene glycol ester),
One in sorbitan aliphatic ester (sorbitan acid), sucrose fatty ester (sucrose ester), lecithin, monoglyceride, Tween 80
Kind is a variety of;The wall material is selected from sodium carboxymethylcellulose, gelatin, carragheen, xanthans, Arabic gum, maltodextrin, fat egg
In vain, corn syrup, soybean protein isolate, whole-fat milk powder, dietary fiber, inulin, PURE WHEY, oligoisomaltose, soybean
One or more in fiber, lactose, candy sugar powder, emulsifying agent, stabilizer.
The present invention also provides a kind of preparation method of above-mentioned climacteric women tailored version clinical nutrition formula, and it is wet method work
Skill, comprise the following steps:
Step 1) prepare the protein containing predetermined weight number, fat, carbohydrate, dietary fiber, macroelement,
Trace element, vitamin, integration of drinking and medicinal herbs composition, the raw material of natural plants compound and new resource food, in scheduled volume
In water, according to the physical behavior of raw material, added successively according to sequencing, be stirred while addition, raw material is made
Mixed emulsion;
The mixed emulsion temperature that step 1) obtains is maintained at 40-50 DEG C by step 2), and adjustment homogenization pressure makes it protect all the time
Hold between 10-18Mpa, emulsifying homogeneous is carried out to mixed emulsion, then placed emulsion in evaporator, with default technology
Parameter is concentrated, and is sterilized at 85-88 DEG C, obtains concentrate;
The concentrate that step 2) obtains is spray-dried by step 3), is crossed 60~80 mesh sieves, is prepared into powder;Using upper
State powder and be prepared at least one of nutrient powder, nutrition emulsion, capsule, tablet, pill or oral liquid.
In the present invention using include orange, donkey-hide gelatin, orange peel, the root of kudzu vine, sea-buckthorn, emblic, Chinese anise integration of drinking and medicinal herbs into
Point, there is the effect of regulation equilibrium between yin and yang and function, resistance building, anti-aging, energy after mentioned component compatibility synergy
It is effectively improved the organism physiology, biochemistry and immunologic function of climacteric patient.
It is orange that there is obvious correction disorders of lipid metabolism, cholesterolemia, triglyceride and beta Lipoprotein are reduced, softens blood
Pipe, improve microcirculation, antiatherosclerosis, suppress platelet aggregation and reduce blood viscosity, be advantageous to blood circulation, accelerate
The effect of removing and the excretion of lipid residual particles (waste);Pummelo peel general flavone has obvious to chronic alcohol liver injury
Protective effect, general flavone have obvious oxidation resistant effect;Orange volatile oil has gentle stimulation to intestines and stomach, is advantageous to
The discharge of gastrointestinal pneumatosis, and the secretion of gastric juice can be promoted, help to digest;Volatile oil can also stimulate respiratory mucosa, make secretion
Thing increases, and sputum dilution, is advantageous to discharge;There is significant antibechic, eliminating the phlegm, anti-inflammatory, bacteriostasis simultaneously.
There is donkey-hide gelatin significant anti-anemia action to act on, and significantly shorten the external clotting time, moreover it is possible to blood loss anemia is treated, its
There are promotion and protective effect to accompany and draw the hematopoiesis function of medulla hematopoietic system;Red blood cell, blood red egg of the donkey-hide gelatin to ischemic animal
White etc. to have significant facilitation, the propagation and differentiation donkey-hide gelatin that can promote body candidate stem cell also have Antishock function,
And it can improve calcium balance in animal body, promote Healthy Individuals transformation.
Orange peel has conditioning digestive system, strengthens functions of intestines and stomach, and cholagogic is aid digestion, reduces, is digested not for insufficiency of the spleen diet
Good and nausea and vomiting etc..Orange peel can promote the secretion of digestive juice, exclude enteral pneumatosis.Intestines caused by anti-acetylcholine are received
Contracting.Also can intestinal tube spasmodic contraction caused by antagonism pilocarpinum and barium chloride.Shorten the Migrating Myoelectric Complex week of small intestine
Phase, improve the digestive function of small intestine.Active ingredient-aurantiamarin has excitation to stomach smooth muscle, can substantially antagonism Ah
Gastric emptying and small intestine push inhibitory action caused by tropine, adrenaline.Hesperidin methyl substantially Inhibition test stomach can burst
The generation of ulcer, and the effect of also anti-gastric acid secretion;Hesperidin methyl can make rat gallbladder contraction, solid in bile and bile
The excretion increase of material, uses VC and VK4 if merging, can strengthen cholagogic effect.
Flavonoid substances in the root of kudzu vine have refrigeration function, and Puerarin has slight reduction blood glucose and prevented and treated diabetes complicated
The effect of disease;The flavones ingredient of separation and purification can significantly inhibit erythrocyte hemolysis caused by oxidative damage from the root of kudzu vine, to micro-
The generation of lipid peroxide has inhibitory action caused by the active oxygen of plastochondria;Kudzu root extract can strengthen macrophage phagocytosis carbon
The function of grain.
Sea-buckthorn contains abundant protein, electrolytes and minerals and unrighted acid, promotes human metabolism,
There can be good action to recovering body.White anthocyanidin, guassin, cumarin contained by sea-buckthorn etc. have obvious antitumaous effect, have
Suppress the effect of sarcoma, melanoma, leukaemia, stomach cancer;Flavones in sea-buckthorn has improvement heart blood supply effect, and the anti-rhythm of the heart loses
Often, anti-hyperlipidemia;SOD of the Seabuckthorn Oil also containing abundant scavenging activated oxygen effect, is important anti-aging material;Sea-buckthorn
In the effective ingredient such as flavones have and remove human free radical, body's immunity can be remarkably reinforced.
Emblic can significantly inhibit the development of acute inflammation, improve and alleviate inflammatory symptoms, and it has reducing blood lipid and resisted dynamic
Pulse atherosclerosis act on;Emblic has stronger lipoid peroxidization resistant, can improve antioxidant ability of organism, has protection
The effect of function of vascular endothelium;Emblic fruit extract can suppress 1,2,3,-thrihydroxy-benzene and adrenergic autooxidation, contain
Active material SOD, it can remove superoxide radical, play its anti-aging effects;Emblic butanol fraction is to real caused by indocin
The property tested gastric mucosa damage has significant protective effect, and it has killing and inhibitory action to fraction of pathogens bacterium;Emblic can strengthen swollen
The NK cells of knurl animal or the activity of K cells, emblic are made to human lymphocyte without induction DNA and chromosome damage in vitro
With body's immunity can be strengthened by being improved cellular immunity with the effect of cell propagation, emblic is suppressed, and improve the disease-resistant energy of human body
Power.
Chinese anise water decoction has inhibitory action to tubercle bacillus and hay bacillus, and its ethanol extract is to golden yellow grape
Coccus, pneumococcus, corynebacterium diphtheriae, comma bacillus right cold bacillus, paratyphosum Bacterium, shigella dysenteriae and some common germs have compared with
High inhibition acts on;Chinese anise also has function of increasing leukocyte, analgesic activity and suppresses platelet aggregation.
Compared with prior art, the invention has the advantages that:
(1) supplement various nutrients general equilibrium of the present invention, at the same add have regulation equilibrium between yin and yang and function,
The integration of drinking and medicinal herbs composition of the effect of resistance building, anti-aging, and effective drug effect is extracted using the method for water extraction alcohol extracting comprehensively
Material, while involutional malaise symptoms are helped improve, the taste ability for improving climacteric women is played, strengthens all kinds of battalion
Support the absorption of material.
(2) ω -6 systems/ω -3 is that the weight ratio of polyunsaturated fatty acid is 4 in nutrient formulation of the present invention:1, meet China
Intake of the crowd to fat matches, and easily absorbs;And blood fat is advantageously reduced, softens blood vessel, reduces blood pressure, promote other
Nutrients Absorption utilizes.
(3) prebiotics such as present invention addition galactooligosaccharide, breed Bifidobacterium in enteron aisle, suppress blood glucose rise, treatment
Constipation, promote the absorption of nutrient ingredients such as vitamin and mineral, reduce serum cholesterol, enhancing immunity of organisms, help fat-reducing.
(4) present invention uses the compound calcium source of scientific matching, selected calcium citrate, L-calcium lactate, calcium monohydrogen phosphate, newborn mineral
Four kinds of compound calcium sources of salt, scientific matching, improve calcium absorptivity and bioavailability, no constipation and gastrointestinal reaction.
(5) CCP is strengthened in nutrient formulation of the invention, CCP (CCP) forms complex compound with calcium, protects
The dissolved state of calcium in the gastrointestinal tract is held, compound amino acid forms solvable state with calcium;Strengthen iron, zinc, iron is the blood red egg of synthesis
White important source material, and form the required composition of various metalloenzyme or the confactor of some metalloenzyme of activation;Zinc participates in dimension
The metabolism of vitamin A is held, the sense of taste, memory function are had a certain impact, zinc participates in cellular immunity and humoral immunity process, preventing and treating
Resistance reduces.
(6) present invention prepares vitamin using micro-capsule embedding techniques, and vitamin is embedded in wall material, can prevent dimension from giving birth to
Element is destroyed by macroelement, trace element, extends the holding time of vitamin;The present invention is prepared using micro-capsule embedding techniques
Powdered oil so that powdered oil has preferable mobility, is easy to be well mixed with other powdered components;And use micro-capsule bag
After burying technology, grease is embedded in wall material, so as to avoid the contact with air to strengthen inoxidizability, is protected so as to play
The maximum effect of strong type grease.
(7) raw material of climacteric women tailored version clinical nutrition formula of the present invention is made in advance in preparation process
For into 150~250 μm of powder, this make it that, when preparing finished product, each nutrition composition can be well mixed, in guarantor unit's volume
Each nutrition composition content it is essentially identical, while when preparing liquid type preparation, each nutrition composition can be fully dispersed and complete
It is dissolved in solvent, prevents occurring solid precipitation in liquid, the effect of finished product product has been effectively ensured.
The present invention is by the way that from rational basal nutrient element, using the proportioning of general equilibrium, while adding has regulation cloudy
Rising tone weighs and function, resistance building, the integration of drinking and medicinal herbs composition of anti-aging, natural plants compound, new resource food
Deng specific nutrient, and its proportioning and basal nutrient element progress compatibility synergy are adjusted, supplement the necessary nutritional ingredient of women comprehensively, and
The nutrient formulation is easier to be digested and assimilated by climacteric women, the effect of giving full play to its each component, adjusts female incretion, changes
Kind premenstrual syndrome and female physiological function;Keep hormone normal secretions, alleviate climacteric various symptoms;Recover to strengthen human body
With the metabolic function of organ, delay bone loss, anti-aging.
Embodiment
The present invention provides a kind of climacteric women tailored version clinical nutrition formula, it is characterised in that including following component and
Its parts by weight:15~20 parts of protein, 12~18 parts of fat, 40~54 parts of carbohydrate, 3.9~5.3 portions of property meals are fine
Dimension, 0.7~1.6 part of macroelement, 0.01~0.04 part of trace element, 0.005~0.02 part of liposoluble vitamin, 0.1~0.2
Part water soluble vitamin, 0.05~2 part of meals elite, 0.2~2 part of integration of drinking and medicinal herbs composition, 0.1~3 part of natural plants compound
And 0.02~2 part of new resource food.In the formula, the weight ratio of ω -6 aliphatic acid and ω -3 aliphatic acid is 4:1;Meals are fine
Dimension includes 3~4 parts of water-soluble dietary fibers and 0.9~1.3 part of insoluble diedairy fiber.
With reference to embodiment, the embodiment of the present invention is further described.Following examples are only used for more
Add and clearly demonstrate technical scheme, and can not be limited the scope of the invention with this.
Embodiment 1
Climacteric women tailored version clinical nutrition formula of the present invention includes PURE WHEY 10.33g, soybean separates
Albumen 5.17g, whole milk powder 12g, bovine colostrum 0.33g, hydrolysis Isin glue collagen 0.17g, taurine 0.12g;Olive oil
2.64g, soybean oil 4.26g, coconut oil 2.64g, perilla herb oil 0.6g, medium chain triglyceride 0.2g;Maltodextrin 34.49g, cassava
Starch 4.94g, rock sugar 6.3g;Water-soluble dietary fiber (including galactooligosaccharide) 3.5g, soybean fiber 1g;Calcium in macroelement
0.43g, phosphorus 0.236g, potassium 0.093g, sodium 0.248g, magnesium 0.148g;Iron 0.011g, zinc 0.008g in trace element;Vitamin A
0.0005g, β-carrotene 0.017g, vitamin D30.000001g, vitamin E 0.009g;Vitamin B10.001g, dimension
Raw plain B20.001g, vitamin B60.001g, vitamin B120.0000013g, vitamin C 0.104g, pantothenic acid 0.003g,
Folic acid 0.00023g, nicotinic acid 0.0133g;Soy meal 1.67g, orange 0.17g, sea-buckthorn 0.17g, donkey-hide gelatin 0.1g, Chinese anise
It is 0.033g, emblic 0.17g, orange peel 0.17g, root of kudzu vine 0.2g, L-arabinose 0.07g, γ-aminobutyric acid 0.033g, left-handed
Carnitine 0.63g, newborn mineral salt 0.1g, CCP 0.03g.
Embodiment 2
Climacteric women tailored version clinical nutrition formula of the present invention includes PURE WHEY 10.33g, soybean separates
Albumen 5.17g, whole milk powder 12g, bovine colostrum 0.33g, hydrolysis Isin glue collagen 0.07g, taurine 0.12g;Olive oil
2.64g, soybean oil 4.26g, coconut oil 2.64g, perilla herb oil 0.6g, medium chain triglyceride 0.2g;Maltodextrin 34.49g, cassava
Starch 4.94g, rock sugar 6.3g;Water-soluble dietary fiber (including galactooligosaccharide) 3.5g, soybean fiber 1g;Calcium in macroelement
0.43g, phosphorus 0.236g, potassium 0.093g, sodium 0.248g, magnesium 0.148g;Iron 0.011g, zinc 0.008g in trace element;Vitamin A
0.0005g, β-carrotene 0.017g, vitamin D30.000001g, vitamin E 0.009g;Vitamin B10.001g, dimension
Raw plain B2 0.001g, vitamin B60.001g, vitamin B120.0000013g, vitamin C 0.104g, pantothenic acid 0.003g,
Folic acid 0.00003g, nicotinic acid 0.0133g;Soy meal 0.07g, orange 0.17g, sea-buckthorn 0.17g, donkey-hide gelatin 0.1g, Chinese anise
It is 0.033g, emblic 0.17g, orange peel 0.17g, root of kudzu vine 0.2g, L-arabinose 0.01g, γ-aminobutyric acid 0.003g, left-handed
Carnitine 0.63g, newborn mineral salt 0.01g, CCP 0.03g.
Embodiment 3
Climacteric women tailored version clinical nutrition formula of the present invention includes PURE WHEY 10.33g, soybean separates
Albumen 5.17g, whole milk powder 12g, bovine colostrum 0.33g, hydrolysis Isin glue collagen 0.07g, taurine 0.12g;Olive oil
2.64g, soybean oil 4.26g, coconut oil 2.64g, perilla herb oil 0.6g, medium chain triglyceride 0.2g;Maltodextrin 34.49g, cassava
Starch 4.94g, rock sugar 6.3g;Water-soluble dietary fiber (including galactooligosaccharide) 3.5g, soybean fiber 1g;Calcium in macroelement
0.43g, phosphorus 0.236g, potassium 0.093g, sodium 0.248g, magnesium 0.148g;Iron 0.011g, zinc 0.008g in trace element;Vitamin A
0.0005g, β-carrotene 0.017g, vitamin D30.000001g, vitamin E 0.009g;Vitamin B10.001g, dimension
Raw plain B20.001g, vitamin B60.001g, vitamin B120.0000013g, vitamin C 0.104g, pantothenic acid 0.003g,
Folic acid 0.00003g, nicotinic acid 0.0133g;Soy meal 0.07g, orange 0.07g, sea-buckthorn 0.07g, donkey-hide gelatin 0.01g, Chinese anise
It is 0.003g, emblic 0.07g, orange peel 0.07g, root of kudzu vine 0.02g, L-arabinose 0.01g, γ-aminobutyric acid 0.003g, left-handed
Carnitine 0.63g, newborn mineral salt 0.01g, CCP 0.03g.
Embodiment 4
A kind of preparation method of the special clinical nutrition formula of climacteric women as described in 1~embodiment of embodiment 3 is as follows:
1) powdered oil (powder fat) is prepared:
A) the wall material aqueous solution is prepared:Take 8 grams of maltodextrin, 4 grams of soybean protein isolate, 11 grams of whole-fat milk powder, dietary fiber 2
Gram (resistant dextrin), 0.5 gram of inulin, 5 grams of PURE WHEY, 0.5 gram of oligoisomaltose, 1 gram of soybean fiber, Arabic gum
0.2 gram, 0.5 gram of lactose, 2 grams of candy sugar powder, 50 milliliters of water stirs and (has ready conditions and heat while stirring to 60 DEG C, kept for 30 points
Room temperature is cooled to after clock).
B) 0.1 gram (total solid concentration is 0.2%) is taken uniformly to be dissolved in (olive oil in 9.71 milliliters of greases monoglyceride
2.48 milliliters, 4.00 milliliters of soybean oil, 2.48 milliliters of coconut oil, 0.56 milliliter of perilla herb oil, 0.19 milliliter of medium chain triglyceride).
C) 0.1 gram (total solid concentration is 0.2%) is taken uniformly to be dissolved in the wall material aqueous solution Tween 80.
D) the wall material aqueous solution of the mixed plant grease and addition Over emulsfication agent Tween 80 of Over emulsfication agent monoglyceride will be added
It is sufficiently mixed.
E) after addition stabilizer agar takes 0.1 gram (total solid concentration is 0.2%) to enter mixed solution, it is settled to water
200 milliliters (total solid concentration be 25%), disperse 2 minutes at a high speed under 20000r/min.
F) homogenization pressure is 25MPa, homogeneous 3 times (every time 5 minutes), homogeneous emulsion is made.
G) obtained emulsion is spray-dried, EAT is 195 DEG C, and leaving air temp is 80 DEG C.Collect powder
Grease (powder fat).
2) integration of drinking and medicinal herbs component powders are prepared:The raw material of predetermined weight number is crushed using pulverizer, will be crushed
Raw material be placed in container, the raw material of predetermined weight number is crushed using pulverizer, the raw material of crushing is placed in container
In, 3~5 times of 60~80% ethanol that weight is raw material weight are added, is soaked, extracted 2 times, merges alcohol extract and concentrates
To without alcohol taste;After the active compound dregs of a decoction fling to ethanol, add weight and soaked for 6~8 times of water of raw material weight, soak is entered
Row decocts 30~60min, filters off except raw material, leaves and takes decoction liquor;Merge alcohol extract and decoction liquor after concentration, and it is carried out
Spray drying, finally prepare integration of drinking and medicinal herbs component powders with 60~80 mesh sieves point;
3) vitamin powder is prepared:Using the liposoluble vitamin of predetermined weight number as core, from oligomeric different malt
Sugar is used as wall material, carries out 2 emulsifying homogeneous processing under high pressure, the emulsifying homogeneous time is 10~15min, then carries out spraying wink
When dry, point prepare liposoluble vitamin powder with 60~80 mesh sieves;Using the water soluble vitamin of predetermined weight number as core
Material, from maltodextrin, oligoisomaltose as wall material, it is well mixed, sprays instantaneous dry, prepared with 60~80 mesh sieves point
Water soluble vitamin powder;
4) by the protein of predetermined weight, carbohydrate, dietary fiber, macroelement, trace element, meals elite,
Natural plants compound and new resource food are prepared into the powder that particle diameter is 150~250 μm respectively;(step 1) -4) order
Can mutually it change)
5) by step 1) -4) prepare powder in the similar devices such as mixer be well mixed after sterilize it is standby;
6) the prepared food powder in step 5) is prepared into by the prepared food powder obtained by step 5) according to conventional technical means
At least one of nutrient powder, nutrition emulsion, capsule, tablet, pill or oral liquid.
In step 6), optionally increase appropriate food thickening agent, food additives and related formulation auxiliary material.
The food thickening agent is in guar gum, xanthans, locust bean gum, konjac glucomannan, pectin, carragheen, agar, gelatin, Arabic gum
At least one, the food additives are Aspartame, flavoring essence spices, at least one of brown sugar;More preferably OK a karaoke club
Glue, Arabic gum, guar gum, Aspartame, flavoring essence spices.
Aforesaid operations step is both needed to carry out under the protection of inert gas, such as nitrogen, argon gas, helium etc., to prevent from producing
The danger of green powder blast.
According to described with the classifications such as powdery, graininess, capsule shape, tablet shape, beverage can be prepared into.
Embodiment 5
1) influence of nutrient formulation preparation prepared by the present invention to normal mouse;
A) acute toxicity test;
The nutrient powder prepared with the embodiment of the present invention 2,1 group of little Bai is given with 150 times of clinical consumption per day and 200 times respectively
Mouse feeding is offerd medicine, and is observed 14;As a result all small white mouses are strong deposits, and its activity, diet, hair, excreta are no abnormal, have no
Toxic reaction.Irritation test is carried out to white mouse oral cavity and damaged skin, there are no irritative response and other adverse reactions.
B) long term toxicity test;
Nutrition powder prepared by the embodiment of the present invention 1 is dissolved in water to mouse by 3,10 and 24g nutrient powders/kg, to 3
Group mouse difference continuous use 12 weeks, 2 times a day, and after drug withdrawal 4 weeks, the results showed that:Chinese medicine of the present invention is to two groups of test mices
Hair, behavior, stool and urine, body weight, organ weights, blood picture, hepatic and renal function, blood glucose, the index such as blood fat have no significant effect, it is dirty
Device naked eyes are without finding that difference change and histological indications show, after medication 12 weeks and drug withdrawal 4 weeks, the equal nothing of Organs of Mice
It is obvious to change.Illustrate that nutrient formulation preparation of the present invention to small toxicity after mouse long-term prescription, does not have abnormal reaction yet, answered after drug withdrawal
With safety.
2) therapeutic effect of nutrient formulation preparation prepared by the present invention to climacteric women patient;
The special clinical nutrition powder of climacteric women and comparative example provided from embodiment 1~3 (does not add integration of drinking and medicinal herbs
The nutrient powder of composition) and control group (using hormone therapy), 100 climacteric women patients are chosen, 5 groups are divided into, to every
One group is tested and is tracked interview.Experiment 6 months by a definite date, after 6 months are full, survey is carried out to every patient, for
The nutrient powder is scored in terms of appetite is improved, improve constitution, improvement mood, improvement sleep and enhancing memory five, full marks
10 points, for patient according to actual conditions to dividing and averaging, result of calculation is as shown in the table shown.
As it can be seen from table 1 the special clinical nutrition powder of climacteric women that the embodiment of the present invention 1~3 is provided is improving
Appetite, the constitution that improves, the mood that improves, improvement sleep and the effect of enhancing five aspects of memory are respectively provided with the effect of preferable, its effect
Fruit is suitable with the hormone therapy effect that control group uses, but its side effect is less compared with control group;The effect of embodiment 1~3 is better than
Comparative example.This absolutely proves the special clinical nutrition of climacteric women provided by the invention with can be to the situation of climacteric metancholia
There is more obvious improvement, and its component can act synergistically with integration of drinking and medicinal herbs composition.
From above-described embodiment, various components are mutual in the special clinical nutrition formula of climacteric women of the present invention
Coordinate, reasonable, comprehensive nutritional support is provided for climacteric women patient, to improve the condition of climacteric women patient,
Addition has regulation equilibrium between yin and yang and function, resistance building, integration of drinking and medicinal herbs composition, the natural plants of anti-aging simultaneously
Compound, new resource food, passive protective physical fitness is improved, anti-aging, realizes the more preferable transition of Menopause.
The specific embodiment of the present invention is described in detail above, but it is only used as example, and the present invention is not intended to limit
In particular embodiments described above.To those skilled in the art, it is any to the equivalent modifications that carry out of the present invention and to replace
In generation, is also all among scope of the invention.Therefore, the impartial conversion made without departing from the spirit and scope of the invention and repair
Change, all should be contained within the scope of the invention.
Claims (9)
1. a kind of climacteric women tailored version clinical nutrition formula, it is characterised in that including following component and its parts by weight:15
~20 parts of protein, 12~18 parts of fat, 40~54 parts of carbohydrate, 3.9~5.3 parts of property dietary fibers, 0.7~1.6 part
Macroelement, 0.01~0.04 part of trace element, 0.005~0.02 part of liposoluble vitamin, 0.1~0.2 part of water soluble vitamin life
Element, 0.05~2 part of meals elite, 0.2~2 part of integration of drinking and medicinal herbs composition, 0.1~3 part of natural plants compound and 0.02~2 part
New resource food;
Wherein, the integration of drinking and medicinal herbs composition is in Poria cocos, orange, donkey-hide gelatin, orange peel, the root of kudzu vine, sea-buckthorn, emblic, Chinese anise
At least one;
Wherein, the dietary fiber includes 3~4 parts of water-soluble dietary fibers and 0.9~1.3 part of insoluble diedairy fiber.
2. a kind of climacteric women tailored version clinical nutrition formula according to claim 1, it is characterised in that in above-mentioned battalion
Support in formula, the weight ratio of ω -6 aliphatic acid and omega-fatty acid is 4:1.
A kind of 3. climacteric women tailored version clinical nutrition formula according to claim 1, it is characterised in that the new money
Source food is selected from first milk basic protein, γ-aminobutyric acid, chitosan oligosaccharide, eucommia Bark male flower, bamboo-leaves flavones, CPP, oat
Beta glucan, Oligomeric manna sugar, stachyose, Rosa roxburghii, yeast beta-dextran, newborn mineral salt, pueraria root powder, Rosa roxburghii, xylo-oligosaccharide, L-
At least one of arabinose.
A kind of 4. climacteric women tailored version clinical nutrition formula according to claim 3, it is characterised in that the new money
Source food is newborn mineral salt, L-arabinose, γ-aminobutyric acid.
A kind of 5. climacteric women tailored version clinical nutrition formula according to claim 1, it is characterised in that the medicine food
It is orange, donkey-hide gelatin, orange peel, the root of kudzu vine, sea-buckthorn, emblic, Chinese anise with derived components.
A kind of 6. climacteric women tailored version clinical nutrition formula according to claim 5, it is characterised in that the medicine food
Parts by weight with derived components are as follows:Orange 0~1 part, 0~1 part of donkey-hide gelatin, 0~1 part of orange peel, 0~1 part of the root of kudzu vine, sea-buckthorn 0~1
Part, 0~1 part of emblic, 0~1 part of Chinese anise.
7. a kind of climacteric women tailored version clinical nutrition formula according to claim 1, it is characterised in that described natural
Plant compound be selected from l-cn, Glucosamine, FOS, lutein, phytosterol, lycopene, resveratrol,
At least one of allicin.
8. a kind of preparation method of such as climacteric women tailored version clinical nutrition formula according to any one of claims 1 to 7,
It is characterised in that it includes following steps:
The fat, liposoluble vitamin, water soluble vitamin of step (1) predetermined weight are respectively adopted micro-capsule embedding techniques and prepared simultaneously
Cross 60~80 mesh sieves and powder is made;
The integration of drinking and medicinal herbs composition of step (2) predetermined weight is made up of crushing, alcohol extracting, water extraction, spray drying and 60-80 mesh sieves excessively
Powder;
Remaining component of step (3) predetermined weight is prepared into the powder that particle diameter is 150~250 μm respectively;
The powder that step (4) prepares step (1)~(3) is sterilized standby after being well mixed;
Direct-edible pharmaceutical formulation is made in step (4) mixed powder by step (5);
Wherein, the order of step (1)~(3) can be changed mutually;The pharmaceutical formulation include nutrient powder, nutrition emulsion, capsule,
Tablet, pill, oral liquid.
9. according to the preparation method of climacteric women tailored version clinical nutrition formula according to any one of claims 1 to 7, its
It is characterised by, comprises the following steps:
Step 1) prepares the protein containing predetermined weight number and amino acid, nucleotides, fat, carbohydrate, meals are fine
Dimension, macroelement, trace element, vitamin, integration of drinking and medicinal herbs composition, the raw material of natural plants compound and new resource food
Powder, in the water of scheduled volume, according to the physical behavior of raw material, add according to sequencing, enter while addition successively
Row stirring, the mixed emulsion of raw material is made;
The mixed emulsion that step 2) obtains step 1) carries out emulsifying homogeneous, concentrating sterilizing, obtains concentrate;
The concentrate that step 2) obtains is spray-dried by step 3), sieving, is prepared into powder, and above-mentioned powder is prepared into
At least one of nutrient powder, nutrition emulsion, capsule, tablet, pill or oral liquid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710730062.1A CN107440102A (en) | 2017-08-23 | 2017-08-23 | A kind of climacteric women tailored version clinical nutrition formula and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710730062.1A CN107440102A (en) | 2017-08-23 | 2017-08-23 | A kind of climacteric women tailored version clinical nutrition formula and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107440102A true CN107440102A (en) | 2017-12-08 |
Family
ID=60493795
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710730062.1A Pending CN107440102A (en) | 2017-08-23 | 2017-08-23 | A kind of climacteric women tailored version clinical nutrition formula and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107440102A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108095075A (en) * | 2017-12-13 | 2018-06-01 | 上海奥医生物医药科技有限公司 | Miscarriage women tailored version clinical nutrition formula and preparation method thereof |
CN108514109A (en) * | 2018-05-10 | 2018-09-11 | 上海奥医生物医药科技有限公司 | Anaesthetize postoperative tailored version clinical nutrition formula and preparation method thereof |
CN108669540A (en) * | 2018-05-10 | 2018-10-19 | 上海奥医生物医药科技有限公司 | Cerebral apoplexy tailored version clinical nutrition formula and preparation method thereof |
WO2021198957A1 (en) * | 2020-03-31 | 2021-10-07 | E.I.D.- Parry(India) Ltd. | Plant-based nutritional composition, method of preparation and application thereof |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106490605A (en) * | 2016-12-23 | 2017-03-15 | 上海奥医生物医药科技有限公司 | A kind of hypertension of pregnancy tailored version clinical nutrition formula and preparation method thereof |
CN106579460A (en) * | 2016-12-23 | 2017-04-26 | 上海奥医生物医药科技有限公司 | Special clinical nutrition formula for fracture and preparation method thereof |
CN106579393A (en) * | 2016-12-23 | 2017-04-26 | 上海奥医生物医药科技有限公司 | Special clinical nutrient formula for diabetes and preparation method thereof |
CN106616615A (en) * | 2016-12-23 | 2017-05-10 | 上海奥医生物医药科技有限公司 | Clinical nutrient formula special for tumor and preparation method of clinical nutrient formula |
CN106666728A (en) * | 2016-12-23 | 2017-05-17 | 上海奥医生物医药科技有限公司 | Special clinical nutrient composition for gestational diabetes and preparation method of nutrient composition |
CN106858595A (en) * | 2017-03-29 | 2017-06-20 | 上海奥医生物医药科技有限公司 | One kind burn tailored version clinical nutrition formula and preparation method thereof |
CN106858620A (en) * | 2017-03-29 | 2017-06-20 | 上海奥医生物医药科技有限公司 | A kind of anaemia tailored version clinical nutrition formula and preparation method thereof |
CN106942748A (en) * | 2017-03-29 | 2017-07-14 | 上海奥医生物医药科技有限公司 | A kind of female acyesis tailored version clinical nutrition formula and preparation method thereof |
CN106962912A (en) * | 2017-03-29 | 2017-07-21 | 上海奥医生物医药科技有限公司 | A kind of hepatopathy tailored version clinical nutrition formula and preparation method thereof |
CN106983151A (en) * | 2017-03-29 | 2017-07-28 | 上海奥医生物医药科技有限公司 | A kind of inflammatory bowel disease tailored version clinical nutrition formula and preparation method thereof |
CN106983136A (en) * | 2017-03-29 | 2017-07-28 | 上海奥医生物医药科技有限公司 | A kind of puerperium conditioning tailored version clinical nutrition formula and preparation method thereof |
-
2017
- 2017-08-23 CN CN201710730062.1A patent/CN107440102A/en active Pending
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106490605A (en) * | 2016-12-23 | 2017-03-15 | 上海奥医生物医药科技有限公司 | A kind of hypertension of pregnancy tailored version clinical nutrition formula and preparation method thereof |
CN106579460A (en) * | 2016-12-23 | 2017-04-26 | 上海奥医生物医药科技有限公司 | Special clinical nutrition formula for fracture and preparation method thereof |
CN106579393A (en) * | 2016-12-23 | 2017-04-26 | 上海奥医生物医药科技有限公司 | Special clinical nutrient formula for diabetes and preparation method thereof |
CN106616615A (en) * | 2016-12-23 | 2017-05-10 | 上海奥医生物医药科技有限公司 | Clinical nutrient formula special for tumor and preparation method of clinical nutrient formula |
CN106666728A (en) * | 2016-12-23 | 2017-05-17 | 上海奥医生物医药科技有限公司 | Special clinical nutrient composition for gestational diabetes and preparation method of nutrient composition |
CN106858595A (en) * | 2017-03-29 | 2017-06-20 | 上海奥医生物医药科技有限公司 | One kind burn tailored version clinical nutrition formula and preparation method thereof |
CN106858620A (en) * | 2017-03-29 | 2017-06-20 | 上海奥医生物医药科技有限公司 | A kind of anaemia tailored version clinical nutrition formula and preparation method thereof |
CN106942748A (en) * | 2017-03-29 | 2017-07-14 | 上海奥医生物医药科技有限公司 | A kind of female acyesis tailored version clinical nutrition formula and preparation method thereof |
CN106962912A (en) * | 2017-03-29 | 2017-07-21 | 上海奥医生物医药科技有限公司 | A kind of hepatopathy tailored version clinical nutrition formula and preparation method thereof |
CN106983151A (en) * | 2017-03-29 | 2017-07-28 | 上海奥医生物医药科技有限公司 | A kind of inflammatory bowel disease tailored version clinical nutrition formula and preparation method thereof |
CN106983136A (en) * | 2017-03-29 | 2017-07-28 | 上海奥医生物医药科技有限公司 | A kind of puerperium conditioning tailored version clinical nutrition formula and preparation method thereof |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108095075A (en) * | 2017-12-13 | 2018-06-01 | 上海奥医生物医药科技有限公司 | Miscarriage women tailored version clinical nutrition formula and preparation method thereof |
CN108514109A (en) * | 2018-05-10 | 2018-09-11 | 上海奥医生物医药科技有限公司 | Anaesthetize postoperative tailored version clinical nutrition formula and preparation method thereof |
CN108669540A (en) * | 2018-05-10 | 2018-10-19 | 上海奥医生物医药科技有限公司 | Cerebral apoplexy tailored version clinical nutrition formula and preparation method thereof |
WO2021198957A1 (en) * | 2020-03-31 | 2021-10-07 | E.I.D.- Parry(India) Ltd. | Plant-based nutritional composition, method of preparation and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107319525A (en) | One kind fat-reducing fat reducing tailored version clinical nutrition formula and preparation method thereof | |
CN106983136A (en) | A kind of puerperium conditioning tailored version clinical nutrition formula and preparation method thereof | |
CN106858620A (en) | A kind of anaemia tailored version clinical nutrition formula and preparation method thereof | |
CN106962912A (en) | A kind of hepatopathy tailored version clinical nutrition formula and preparation method thereof | |
CN109645320A (en) | A kind of light jejunitas full nutrient formulation can brew instant stick and preparation method thereof | |
CN101473953B (en) | Fabricated food for cleaning blood and expelling toxin as well as method for processing the same and application | |
CN108618129A (en) | Sarcopenia tailored version clinical nutrition formula and preparation method thereof | |
CN107242550A (en) | A kind of male sterility tailored version clinical nutrition formula and preparation method thereof | |
CN107440120A (en) | A kind of children's monophagia and anorexia tailored version clinical nutrition formula particular about food and preparation method thereof | |
CN106983151A (en) | A kind of inflammatory bowel disease tailored version clinical nutrition formula and preparation method thereof | |
CN107616490A (en) | A kind of postoperative tailored version clinical nutrition formula of children and preparation method thereof | |
CN107319524A (en) | A kind of nephrosis tailored version clinical nutrition formula and preparation method thereof | |
CN110074397A (en) | A kind of upgrowth and development of children tailored version clinical nutrition formula and preparation method thereof | |
CN107440103A (en) | A kind of respiratory disease tailored version clinical nutrition formula and preparation method thereof | |
CN107440121A (en) | A kind of Single Obesity tailored version clinical nutrition formula and preparation method thereof | |
CN108013454A (en) | Gynaecological imflammation tailored version clinical nutrition formula and preparation method thereof | |
JP2021526821A (en) | Unchanged pea protein-based nutritional composition | |
CN108077911A (en) | A kind of epileptic's tailored version clinical nutrition formula and preparation method thereof | |
CN107440102A (en) | A kind of climacteric women tailored version clinical nutrition formula and preparation method thereof | |
CN107927754A (en) | Tailored version clinical nutrition formula and preparation method thereof is energized during one kind production | |
CN108719984B (en) | Meal replacement nutrition bar for gout population and preparation method thereof | |
CN108013453A (en) | Children's lactose intolerance tailored version clinical nutrition formula and preparation method thereof | |
CN106858595A (en) | One kind burn tailored version clinical nutrition formula and preparation method thereof | |
CN112118748A (en) | Hydrolyzed pea protein based nutritional composition | |
CN108669540A (en) | Cerebral apoplexy tailored version clinical nutrition formula and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171208 |